AtriCure (ATRC) Share-based Compensation (2010 - 2026)

AtriCure (ATRC) has 17 years of Share-based Compensation data on file, last reported at $11.3 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $11.3 million, up 17.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.3 million (up 13.63% YoY), and the FY2025 annual result was $44.7 million, up 10.59% from the prior year.
• Share-based Compensation was little changed at $11.3 million in Q1 2026 per ATRC's latest filing, from $11.3 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $12.4 million in Q3 2025 and troughed at $7.0 million in Q3 2022.
• A 5-year average of $9.5 million and a median of $9.3 million in 2023 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation fell 4.54% in 2022, then increased 29.39% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $7.2 million in 2022, then advanced by 29.39% to $9.3 million in 2023, then climbed by 11.52% to $10.4 million in 2024, then gained by 8.43% to $11.3 million in 2025, then increased by 0.12% to $11.3 million in 2026.
• Business Quant data shows ATRC's Share-based Compensation at $11.3 million in Q1 2026, $11.3 million in Q4 2025, and $12.4 million in Q3 2025.